Table 4.
Fatty acid composition of total erythrocyte membrane lipids at baseline and 3 monthsa)
Fatty acid | Time | Fish (n = 12) Mean ± SD | Capsules (n = 13) Mean ± SD |
---|---|---|---|
C14:0 | 0 | 0.38 ± 0.13 | 0.39 ± 0.11 |
3 | 0.33 ± 0.07 | 0.39 ± 0.14 | |
C16:0 | 0 | 24.47 ± 1.59 | 24.28 ± 2.16 |
3 | 23.56 ± 1.56 | 23.80 ± 2.59 | |
C16:1n7 | 0 | 0.71 ± 0.29 | 0.62 ± 0.18 |
3 | 0.58 ± 0.22 | 0.65 ± 0.30 | |
C18:0 | 0 | 19.88 ± 1.37 | 19.75 ± 1.32 |
3 | 19.51 ± 1.07 | 19.39 ± 1.42 | |
C18:1n9 | 0 | 12.99 ± 0.76 | 12.81 ± 0.98 |
3 | 13.31 ± 1.11 | 12.96 ± 0.98 | |
LA | 0 | 13.24 ± 1.90 | 13.76 ± 2.44 |
3 | 13.85 ± 2.18 | 13.61 ± 1.81 | |
C18:3n3 | 0 | 0.19 ± 0.07 | 0.34 ± 0.44 |
3 | 0.18 ± 0.06 | 0.18 ± 0.07 | |
C20:2n6 | 0 | 0.51 ± 0.35 | 0.45 ± 0.15 |
3 | 0.41 ± 0.08 | 0.52 ± 0.40 | |
C20:3n6 | 0 | 1.89 ± 0.46 | 1.81 ± 0.31 |
3 | 1.76 ± 0.40 | 1.55 ± 0.29 | |
AA | 0 | 15.38 ± 1.35 | 15.75 ± 0.92 |
3 | 14.43 ± 1.11 | 14.34 ± 2.07 | |
EPAb) | 0 | 0.59 ± 0.28 | 0.44 ± 0.15 |
3 | 1.21 ± 0.53 | 1.71 ± 0.53 | |
C22:4n6 | 0 | 3.30 ± 0.80 | 3.64 ±0.52 |
3 | 2.50 ± 0.51 | 2.54 ± 0.63 | |
C22:5n6 | 0 | 0.46 ± 0.16 | 0.46 ± 0.14 |
3 | 0.33 ± 0.16 | 0.38 ± 0.16 | |
C22:5n3b) | 0 | 2.37 ± 0.42 | 2.36 ± 0.64 |
3 | 2.56 ± 0.48 | 2.93 ± 0.23 | |
DHAb) | 0 | 3.64 ± 1.34 | 3.13 ± 0.77 |
3 | 5.48 ± 1.44 | 5.03 ± 0.74 | |
n3/n6b)’c) | 0 | 0.20 ± 0.06 | 0.18 ± 0.03 |
3 | 0.29 ± 0.09 | 0.30 ± 0.06 |
Values are expressed as mean % of total fatty acids ± SD.
3 month values are significantly higher than baseline,
p < 0.0001.
The n-3/n-6 ratio represents the sum of [18:3n3, 20:5n3, 22:5n3, 22:6n3]/sum of [18:2n6, 20:2n6, 20:3n6, 20:4n6, 22:4n6, 22:5n6].